Univ of WI PT

8/2/2019 Univ of WI PT

1/44

www.wslhpt.org 800-462-5261

!

General Information!"#$%&'%()*+,-.+)%.)/%&+012134%%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%% 6789),+00-3):%()*+,-.+)% %5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%% ;7%2+))P34%1:4%:,./1+)%+*%,34@+)/1)>%:+%2P4:+-3,%)33/4%1)%.%-30A%-.))3,5%%&,+/P2:4%.,3%.//3/%:I,+P>I+P::I3%A3.,%1*%[email protected]%4.-@034%.)/%4P%213):%1):3,34:%.00+V%P4%:+%@,+G1/3%:I3%)33/3/%43,G12345%%=P,%+)01)3%2.:.0+>%WVVV5V40I@:+,>X2.:.0+>Y%V100%T3%P@/.:3/%:+%,3"32:%.)A%2I.)>34%-./3%/P,1)>%:I3%2.03)/.,%A3.,5%

'I3%014:%T30+V%1)20P/34%)3V%43,G1234%*+,%6KJ6%1)%.//1+)%:+%:I+43%1):,+/P23/%.3,%:I3%6KJJ%2.:.0+>%V.4%@,1):3/Z%

[9!%@,+/P2:4%.)/%.).0A:34

L0++/%M.4%$3-+>0+T1)X$3-.:+2,1:%*+,%9&=?\%M9F\%.)/%+:I3,%4A4:3-4Z%%S//7+)%@,+/P2:%*+,%L0++/%M.4X9032:,+0A:34XF3:.T+01:34%W@.>3%JKY

9032:,+0A:34XF3:.T+01:34%!.1G3/%F3:I+/4Z%%[email protected]%V1:I%!"#$%$%V.1G3/%2.,:,1/>34%W@.>3%JKY

I?M\]P.):.G3%W43,P-YZ%%[+V%1)20P/3/%1)%?I3-14:,AX9)/+2,1)+0+>AX'I3,.@3P2%^,P>4%@,+/P2:%W@.>3%JJY

(>F%UPT300.Z%%[3V%.).0A:3%*+,%UPT300.%W@.>3%6CY

([U%!.1G3/%F3:I+/Z%%([U%*+,%?+.>P?I3Q%_"%W@.>3%JEY

&,+/P2:%,32+)!>P,.+)4

!I+03%L0++/%M0P2+43Z%%?P4:+-3,4%)+V%+,/3,%TA%:I3%)P-T3,%+*%,34P0:%43:4%,3@+,:3/5%%W@.>3%JBY

`P.01:A%4.-@034%.)/%4P@3,1+,%2P4:+-3,%43,G123

!3aG3%.0V.A4%@,1/3/%+P,430G34%+)%@,+G1/1)>%I1>I%]P.01:A%4.-@034%.)/%*,13)/0A\%I.)/47+)%2P4:+-3,%43,G1235%%?.00%+P,%Q)+V03/>3.T03%

.)/%3b%@3%,1%3)23/%-3/12.0%:32I)+0+>14:4%V1:I%]P34+)4%.)/%:I3Aa00%T3%I.@@A%:+%I30@Z%%EKK7;B67


3/44


#

$+V%!"#$%&'%?.)%$30@%g+P%F33:%S22,3/1:.+)%U3]P1,3-3):4

&.,21@.+)%1)%@,+!213)2A%:34)>%W&'Y%14%,3]P1,3/%*+,%.).0A:34%014:3/%1)%?#(S%aEE%.)/%:34:3/%TA%)+)7V.1G3/%-3:I+/45%%?#(S%hEE%

.).0A:34%.,3%@,1):3/%1)%$%&'(%1)Q5%%[+)7,3>P0.:3/%.).0A:34%.,3%@,1):3/%1)%:3.05

9G3)%1*%A+P,%0.Th4%:34:%-3)P%+)0A%2+)414:4%+*%)+)7,3>P0.:3/%.).0A:34%.)/X+,%V.1G3/%-3:I+/4\%?#(S%/12:.:34%:I.:%0.T4%-P4:%I.G3%

.%]P.01:A%.44P,.)23%@0.)%:I.:%34:.T014I34%:I3%.22P,.2A%.)/%,301.T101:A%*+,%:I+43%:34:45%%S%2+)G3)13):%.)/%+3)%2+4:7332G3%V.A%

:+%.22+-@014I%:I14%14%:+%+,/3,%&'%43,G12345

O.210134%.22,3/1:3/%TA%.>3)2134%4P2I%.4%?S&\%i+1):%?+--1441+)%+,%?=#S\%+,%:I.:%.,3%0+2.:3/%1)%23,:.1)%4:.:34\%-.A%T3%,3]P1,3/%:+%3),+00%1)%&'%*+,%?#(S%)+)7,3>P0.:3/%.).0A:34%.)/X+,%:34 )>%@3,*+,-3/%TA%V.1G3/%-3:I+/4%T32.P43%4:.)/.,/4%*+,%:I343%.>3)2134%

3b233/%VI.:%14%,3]P1,3/%TA%?#(S5%%!3%+3,%-.)A%&'%@,+/P2:4%:I.:%*P0!00%:I343%,3]P1,3-3):45

!"#$%&'%+3,4%43,G1234%T3A+)/%&'%:+%.4414:%0.T4%V1:I%+:I3,%.22,3/1:.+)%,3]P1,3-3):4Z

D3,1".-@%G.01/.+)%4.-@034%2.)%T3%P43/%*+,%-3:I+/%G3,1!2.+)%.)/%:,.1)1)>5%

=)01)3%#.T%.)/%&,+G1/3,%&3,*+,-3/%F12,+42+@A%?+-@3:3)2A%.)/%:I3%',.1)1)>%#1T,.,A%@,+G1/3%?9R4\%2+)G3)13):%

.22344\%:,.2Q1)>\%.)/%/+2P-3):.+)%*+,%:I343%G1:.0%*P)2+)45

`P.01:A%-.).>3-3):%,3@+,:%14%.)%3.4A%V.A%:+%,3G13V%.00%&'%/.:.%3b23@+)4%+)%.%]P.,:3,0A%T.4145

&,37()4@32+)%U3@+,:%1/3)!34%&'%/.:.%,3]P1,1)>%.//1+).0%.3)+)%.)/%2.)%T3%+,/3,3/%+)%/3-.)/%@,1+,%:+%.)%+)7

41:3%1)4@32+)5

O+,%.//1+).0%1)*+,-.+)%+)%:I343%43,G1234\%@03.43%,3G13V%:I3%1)*+,-. +)%1)%:I3%&'1234%432+)%+*%:I14%2.:.0+>%4:.,)>%+)%@.>3%B%+,%2.00%EKK7;B67%G1.%R&"%14%1)20P/3/%1)%:I3%@,123%+*%3.2I%@,+/P2:5%%S//1+).0%2I.,>34%*+,%[email protected]%43,G1234%W35>5\%O3/%9b\%+G3,)1>I:Y%+,%4I1@-3):%+P:41/3%:I3%;E%2+)>P+P4%4:.:34%W35>5\%$.V.11\%S0.4Q.\%?.)./.\%3:25Y%V100%T3%.@@013/5%(-@+,:%@3,-1:4%*+,%1):3,).+).0%0.T4%-P4:%T3%@,+G1/3/%TA%2P4:+-3,4%.:%03.4:%+)3%-+):I%@,1+,%:+%:I3%!,4:%42I3/P03/%4I1@-3):5%

S"9%[='9Z%^.:34%014:3/%1)%:I14%2.:.0+>%.,3%*+,%>3)3,.0%,3*3,3)23%+)0Aj%%S% !).0%4I1@%@1)>%42I3/%P03%V100%2+-3%V1:I%A+P,%3)%,+00%-3):%2+)%!,%-.%+)%033,5

".-@03%[email protected]):

(*%4.-@034%.,3%-1441)>%+,%/.-.>3/%1)%:,.)41:\%@03.43%2.00% )**+,-"+."-!/0*%:+%,3]P34:%,3%@0.23%-3):4%V1:I1)%:I3%-3%*,.-3%)+:3/%+)%:I3%1)4:,P2+)45%%S%,[email protected]):%*33%V100%T3%2I.,>3/%*+,%4.-%@034%VI12I%I.G3%T33)%-14%I.)%/03/%TA%:I3%@.,21@.):%W-14/10P+)\%4@100.>3\%1-@,+@3,%4:+,.>3\%3:25Y5

?.)2300.+)%+*%&'%&,+/P2:4

OP00%,3*P)/4%V100%T3%-./3%*+,%@,+/P2:%2.)2300. +)4%,3]P34:3/\%1)%V,1)>\%-+,3%:I.)%8K%2.0%3)%/.,%/.A4%T3*+,3%.%@,+/P2:a4%!,4:%4I1@-3):%/.:35%&.,.0%,3*P)/4%V100%T3%-./3%*+,%2.)2300. +)4%,3]P34:3/%.:%03.4:%8K%2.03)/.,%/.A4%T3*+,3%.)A%4PT%43%]P3):%4I1@%-3):45%%U3*P)/%

2I32Q4\%1*%,3]P34:3/\%V100%T3%144P3/%V1:I1)%*+P,%:+%41b%V33Q45%%"1)23%.))P.0%.2 G3%3)%,+00%-3):%4:.:P4%-P4:%T3%-.1)%:.1)3/\%V3%V100%)+:%,3T.:3%.%@,+7,.:3/%*33%/P3%:+%:3-@+,.,A%4P4@3)41+)%+*%:34)>5%%'I3%.))P.0%3)%,+00%-3):%*33%14%)+)7,3*P)/.T035

WSLH PT Policies


4/44

3,-,'456-)('741*(


,

How Do I Enroll?

'+%.44P,3%A+P,%0.Ta4%@.,21@.+)%1)%.00%4I1@-3):4\%6KJ6%+,/3,4%-P4:%T3%,3231G3/%TA%12'3/!4/"*!!5

9),+00-3):%.)/%=,/3,%*+,-4

U3G13V%2.:.0+>%.)/%!00%+P:%.00%.@@,+@,1.:3%*+,-45%%?P,,3):%2P4:+-3,4%3/1:%A+P,%U379),+00-3):%*+,-%.4%)33/3/5

'I3%*+00+V1)>%*+,-4%.,3%3)20+43/%1)%:I14%2.:.0+>%.)/%.,3%.04+%.G.10.T03%+)%+P,%V3T41:3%.:%VVV5V40I@:5+,>k2.:.0+>

&,+!213)2A%'34)>%9),+00-3):%O+,-

7% (*%&'%43,G1234%.,3%T31)>%+,/3,3/%*+,%:34)>%/+)3%P)/3,%-+,3%:I.)%+)3%?#(S%(^l\%.%43@.,.:3%3),+00-3):%*+,-%-P4:%T3!003/%+P:%*+,%3.2I5

7% O+,%F.).>3-3):%"3,G1234%+@+)%433%@.>3%H%*+,%-+,3%/3:.104%+*%43,G1234%.G.10.T035

S22,3/1:.+)%()*+,-.+)%O+,-

7% ?P4:+-3,4%.22,3/1:3/%TA%:I3%?+003>3%+*%S-3,12.)%&.:I+0+>14:4%#.T+,.:+,A%S22,3/1:.+)%&,+>,.-%W#S&Y%@03.43%,3*3:+%@.>3%%=)01)3%S22+P):4%O+,-

&,+!213)2A%'34)>%=,/3,%O+,-

7% &,+/P2:%'A@3%()*+,-.+)

R)0344%+:I3,V143%4@321!3/%1)%:I3%@,+/P2:%014)>%1)%:I14%2.:.0+>\%3.2I%4I1@-3):%+*%3.2I%@,+/P2:%:A@3%1)20P/34%:I3*+00+V1)>Z

5647,89:;3%%=)3%43:%+*%4.-@034%.)/%,3@+,)>%*+,%+)3%43:%+*%,34P0:45

%;;!:?62,46@8274>,%=)3%.//1+).0%43:%+*%4.-@0345%%S//1+).0%4.-@034%-.A%+)0A%T3%+,/3,3/%1)%2+)dP)2+)%V1:I

.%2+,,34@+)/1)>%T.43%@,+/P2:5

%;;!:?62,97432=,978:9?A>%%U3@+,)>%*+,%+)3%.//1+).0%43:%+*%,34P0:45%%S//1+).0%,34P0:%,3@+,)>%-.A%+)0A%T3

+,/3,3/%1)%2+)dP)2+)%V1:I%.%2+,,34@+)/1)>%T.43%@,+/P2:5%%S//1 +).0%,34P0:%43:4%-P4:%+@3,.:3%P)/3,%:I3%4.-3

?#(S%(^%)P-T3,5

7% &,123%()*+,-.+)

&,+/P2:%@,123%1)20P/34%.00%4I1@-3):4%1)%:I3%2.03)/.,%A3.,5

?P4:+-3,4%3),+001)>%.

3,%:I3%!

,4:%+*%:I3%A3.,%V100%T3%2I.,>3/%+)0A%*+,%:I3%)P-T3,%+*%4I1@-3):4%:I3A%V100%,3231G3*,+-%+,/3,%@,+2344%/.:3%:I,+P>I%:I3%3)/%+*%:I3%A3.,5%%%&,1234%.,3%/1G141T03%TA%:I3%)P-T3,%+*%4I1@-3):4%@3,%A3.,5

&'%&0P4%=)01)3%&,+/P2:4%=,/3,%O+,-

&'%&0P4%D3,1".-@%&,+/P2:4%=,/3,%O+,-

F3:I+/%+*%&.A-3):

O+,%*.210134%:I.:%,3]P1,3%.%&P,2I.43%=,/3,%)P-T3,%T3%.441>)3/%VI3)3G3,%@0.21)>%.)%+,/3,\%@03.43%014:%:I3%&=l%+)%+,/3,%*+,-4

&P,2I.43%=,/3,%)P-T3,4%V100%T3%@,1):3/%+)%:I3%1)G+12345

!3%.223@:%D14.%+,%F.4:3,?.,/5%%O+,%432P,1:A%.)/%.P/1:%,3.4+)4\%@03.43%V.1:%*+,%A+P,%1)G+123%:+%.,,1G3%.)/%:I3)%2.00%:I3%@I+)3%

)P-T3,%+)%:I3%1)G+123%:+%@,+G1/3%2,3/1:%2.,/%1)*+,-.+)5

9),+00-3):%?+)!,-.+)

g+P%V100%,3231G3%.%2+)!,-.+)%033,\% @+012A% 1)*+,-.+)\%.)/% .% 2P4:+-3,%4@321!2%4I1@@1)>%42I3/P03%V1:I1)%:I,33%V33Q4%+*,3231@:%+*%A+P,%+,/3,5


5/44


.

!1:I%:I3%3b23@+)%+*%:I3%.).0A:34%014:3/%T30+V\%:34:4%1)%+P,%2.:.0+>%.,3%.223@:3/%TA%:I3%?S&%#.T+,.:+,A%S22,3/1:. +)%&,+>,.-%W#S&Y%:+%*P0!00%&'%,3]P1,3-3):45%%'+%.03,:%2P4:+-3,4%/P,1)>%:I31,%,3G13V%+*%:I3%2.:.0+>%1)*+,-.+)\%.).0A:34%:I.:%.,3%)+:%.223@:3/%.,3%-.,Q3/%V1:I%.%/+PT03%@P,@03%.4:3,14Q%W55Y5

(*%3),+00-3):%1)%&'%14%,3]P1,3/%TA%:I3%#S&%*+,%.)%.).0A:3\%:I3%&'%@,+G1/3,%-P4:%43)/%3),+00-3):%,32+,/4%.)/%42+,34%3032:,+)12.00A%:+%:I3%#S&5%%(*%&'%14%)+:%,3]P1,3/\%:I3%&'%@,+G1/3,%/+34%)+:%43)/%,32+,/4%:+%:I3%#S&5%%$+V3G3,\%2P4:+-3,4%-.A%3),+00%1)%&'%.)/%P43%:I.:%/+2P-3):.+)%:+%4.4*A%:I3%.0:3,).:3%.44344-3):%,3]P1,3-3):%WVI12I%V+P0/%T3%,3G13V3/%/P,1)>%+)741:3%4P,G3A4Y5%%O+,%3b.-@03\%.%#S&%.22,3/1:3/%0.T%14% 678%,3]P1,3/%:+%3),+00%1)%&'%*+,%43/1-3):.+)%,.:3%.)/%+22P0:%T0++/m%:I3A%&92%,3]P1,3/%:+%@3,*+,-%.)%

e.0:3,).:3%.44344-3):f%*+,%:I343%:34:45%%%9),+00-3):%1)%&'%14%+3)%:I3%3.4134:%.)/%-+4:%2+4:%332G3%V.A%:+%/+2P-3):%e.0:3,).:3%.44344-3):f5

#.T+,.:+,134%2.)%/3:3,-1)3%1*%3),+00-3):%1)%&'%14%,3]P1,3/%TA%,3G13V1)>%:I3%1)*+,-.+)%+)%:I31,%#.T+,.:+,A%S2G1:A%F3)P%,3@+,:5

?P,,3):%.)/%@+:3).0%2P4:+-3,4%4I+P0/%2.,3*P00A%,3G13V%:I3%1)*+,-.+)%T30+V%T3*+,3%@0.21)>%:I31,%+,/3,%V1:I%!"#$%&'5%%

(*%A+P,%0.T+,.:+,Aa4%:34:%-3)P%1)20P/34%.)A%+*%:I3%.).0A:34%014:3/%T30+V\%@03.43%2.00%EKK7;B67


6/44

&-5*-,/'4**--

&4-9:(

;,

1,-+.


-

!"#$% &,+!213)2A% '34)>% 14% @03.43/% :+% +3,% +P,% 2P4:+-3,4% :I3% F3/12.0% ',.1)1)>% "+0P+)4% WF'"Y% V3T7T.43/% :,.1)1)>% .)/

2+-@3:3)2A%.44344-3):%@,+/P2:45%%'I343%.V.,/7V1))1)>%@,+/P2:4%I.G3%T33)%/3G30+@3/%TA%F'"%.)/%:I3%R)1G3,41:A%+*%!.4I1)>:+)%

^3@.,:-3):%+*%#.T+,.:+,A%F3/121)3%.)/%2+G3,%.%V1/3%,.)>3%+*%4PTd32:4%@3,)3):%:+%:I3%201)12.0%0.T+,.:+,A5%%9-.10%)+ !2.+)4%:+

4:.%.)/%@,1):.T03%@3,*+,-.)23%,3@+,:4%*+,%./-1)14:,.:+,4%.,3%-374.G1)>%*3.:P,34%VI12I%-.Q3%F'"%:I3%:A@3%+*%]P.01:A\%3.4A7:+7

P43%43,G123%:I.:%V+P0/%-33:%:I3%)33/4%+*%!"#$%&'%2P4:+-3,45

#.T%',.1)1)>%2+G3,4%.%G.,13:A%+*%4.*3:A\%@,37.).0A2.0%.)/%.).0A2.0%:+@1245%%

#.T% ?+-@3:3)2A% .)/% &,+G1/3,% &3,*+,-3/% F12,+42+@A% ?+-@3:3)2A% +3,%.% ]P12Q\%% 1-.>37T.43/\% :3)7]P34+)% *+,-.:5% % [3V

2+-@3:3)2A%]P34+)%43:4%.,3%1):,+/P23/%3.2I%i.)P.,A%J4:%.)/%iP0A%J4:5%%"PT42,1@+)%@,1234%2+G3,%J6%-+):I4%W:V+%e2+-@3:3)2A

@3,1+/4fY5%%&03.43%1)/12.:3%+)%:I3%+,/3,%*+,-%VI12I%4:.,:%/.:3%T34:%-33:4%:I3%)33/4%+*%A+P,%*.2101:A5

Provider Performed Microscopy Competency

%2/:&?2 @7=2

&,+G1/3,%&3,*+,-3/%F12,+42+@A7%%O32.0%4-3.,\%*3,)%:34:\%o=$%@,3@\%).4.0%4-3.,\%@1)V+,-%@,3@\%P,1)3%43/1-3):\%G.>1).0%V3:%@,3@

&'EJHKK

Continuing Education Credits (P.A.C.E.) available in all product lines!

Lab Training

%2/:&?2 @7=2

S00%#.T%',.1)1)>%F+/P034 &'EKKKK

L0++/%L.)Q &'EKKJK

L+/A%O0P1/4%7%.-)1+2\%?"O\%43-1).0\%43,+P4\%.)/%4A)+G1.0 &'EKK6K

M,.-%":.1) &'EKK8K

$3-.:+0+>A &'EKK;K

(--P)+0+>A &'EKK &'EKJ8K

R,1).0A414 &'EKJ;K

Lab Competency

%2/:&?2 @7=2

S00%#.T%?+-@3:3)2A%F+/P034 &'EJKKK

L0++/%L.)Q%7%T.412%.)/%./G.)23/%:I3+,A%.)/%@,.223 &'EJKJK

L+/A%O0P1/4%7%?"O\%43,+P4\%43-3) &'EJK6K

?I3-14:,A &'EJK8K

?+.>P0.:1+) &'EJK;K

M,.-%":.1) &'EJKA &'EJKBK

[email protected]%.)/%$(D &'EJKCK(--P)+0+>A &'EJKEK

F12,+T1+0+>A &'EJKHK

&.3):%".*3:A &'EJJKK

&I03T+:+-A &'EJJJK

&,+:31)%9032:,+@I+,3414 &'EJJ6K

".*3:A &'EJJ8K

"@321-3)%$.)/01)>X&,+23441)>X',.)4@+,: &'EJJ;K

'+b12+0+>A &'EJJ%F+/P034/&6=%S00%#.T%?+-@3:3)2A%F+/P034 &'EKHKK


7/44


A

'+%+,/3,Z%%%%%%%%R43%*+,-%1)%:I14%2.:.0+>%+,%*,+-%+P,%V3T41:3%.:%VVV5V40I@:5+,>%W43032:%&'1-'#%=)01)3%.)/%:I3)%&,121)>%=,/3,%()*+5

O.b%2+-@03:3/%+,/3,%*+,-%:+%BKE76B%+)0AZ%/6%7%;%-+/P034%W@,123%14%@3,%-+/P03Y pJKK

S00%#.T%',.1)1)>%-+/P034%W.00%-+/P034%V100%T3%1)20P/3/%1*%%.)/%S00%#.T%?+-@3:3)2A%-+/P034%W.00%-+/P034%V100%T3%1)20P/3/%1*%E%+,%-+,3%-+/P034%+,/3,3/Y pEKK

&,+G1/3,%&3,*+,-3/%F12,+2+@A%?+-@3:3)2AZ%%=)0A p8KK

=,/3,%V1:I%#.T%',.1)1)>%.)/X+,%#.T%?+-@3:3)2A%W?+/3Z%&'EJHK8Y p6KK

O.2101:134%,3>14:3,1)>%8J7JKK%P43,4%@3,%"#%)P-T3,%W?+/3Z%&'EKHJKY pJKK

&,121)>%014:3/%14%@3,%"#%)P-T3,5%%S%*.2101:A%0123)43%14%.G.10.T03%*+,%-P0741:3%+,>.)1N.+)45

&03.43%2+):.2:%P4%.:%EKK7;B675

Online Training and Competency


8/44


)

,'*"47;

'+%+,/3,Z%%%%%%%%R43%*+,-%1)%:I14%2.:.0+>%+,%*,+-%+P,%V3T41:3%.:%VVV5V40I@:5+,>%W43032:%&'1-'#%=)01)3%.)/%:I3)%&,121)>%=,/3,%()*+5

O.b%2+-@03:3/%+,/3,%*+,-%:+%BKE76B%-3:I+/45

%?+/3Z &'E6KKK

&,123Z pJ3)4%7%()"P3)N.

'I14%@,+/P2:%@,+G1/34%.%43:%+*%!B7%4.-@034%1)20P/1)>%@+41G3%1)"P3)N.%S\%@+41G3%1)"P3)N.%L%.)/%

)3>.G3%4.-@0345

?+/3Z &'E6JKK

&,123Z p6KK

D1,.0%S)>3)4%7%U"D

'I14%@,+/P2:%@,+G1/34%.%43:%+*%!B7%4.-@034%1)20P/1)>%@+41G3%.)/%)3>.G3%4.-@034%*+,%U"D5 %?+/3Z &'E66KK

&,123Z p6KKM,.-%":.1)

'I14%@,+/P2:%@,+G1/34%.%43:%+*%!B7%P)4:.1)3/%401/34%*+,%P43%1)%.443441)>%T+:I%>,.-%4:.1)%:32I)1]P3%

.)/%+,>.)14-%-+,@I+0+>A5

?+/3Z &'E68KK

&,123Z pJKK

G&'H/I29DJ&?C/C97=>'8/D6'%>=2E;

%% U3]P34:3/%4.-@034

% ()4:,P2+)4%@.>3%V1:I%[email protected]%:+%/+2P-3):%:34:%,34P0:4 % S%43.03/%3)G30+@3%2+):.1)1)>%3b@32:3/%:34:%,34P0:4S00%@,+/P2:%@,1234%1)20P/3%4:.)/.,/%4I1@@1)>5


9/44


K

#.T%-.).>3,4\%:32I)12.0%2+)4P0:.):4%.)/%&=?'%2++,/1).:+,4%.,3%+ 3)%@IA412.00A%,3-+G3/%*,+-%:I3%:34 )>%41:34%*+,%VI12I%:I3A%

I.G3%,34@+)41T101:A5%%!"#$%&'%+3,4%43,G1234%VI12I%V3%T3013G3%-.Q3%:I3%3),3%&'%@,+2344%-+,3%3%213):5

?+@134%+*%&'%U3@+,:4% % % % % % [+%.//1+).0%2+4:?+@134%+*%.00%@,+!213)2A%:34)>%,3@+,:4%43):%:+%:I3%3),+003/%41:3W4Y%.0+)>%V1:I%4:.424%.)/%3G3):%4P--.,A%)+:34%2.)%T3%43):%

:+%.%:32I)12.0%2+)4P0:.):\%0.T%/1,32:+,\%-.).>3,%+,%&=?'%2++,/1).:+,%1*%:I3%1)*+,-.+)%14%4P@@013/%:+%P45%%'I343%2+@134%V100%T3%

,303.43/%+)%:I3%4.-3%-3%*,.-3%.4%:I3%2P4:+-3,%0.T45

M,+P@%U373),+00-3):% % % [+%.//1+).0%2+4:'I14%43,G123%14%1):3)/3/%:+%4:,3.-01)3%:I3%,373),+00-3):%@,+2344%q%.)/%1:a4%*,33j%%U373),+00-3):%*+,-4%*+,%.00%41:34%2.)%T3%2+-T1)3/%

1)%.%41)>03%-.101)>%/1,32:0A%:+%+)3%1)/1G1/P.0%,.:I3,%:I.)%3.2I%+*%:I3%0.T%41:345%%'I3%41:34%2.)%T3%1)%:I3%4.-3%I3.0:I%2.,3%4A4:3-%+,%1)%

/13,3):%4A4:3-4%P)/3,%:I3%+G3,41>I:%+*%.%2+)4P0:.):5%%'I14%4.G34%G.0P.T03%-3%1)%:,.2Q1)>%,373),+00-3):%.)/%3)4P,34%:I.:%.00%41:34%

V100%T3%3),+003/%1)%@,+!213)2A%:34)>%*+,%:I3%)3V%A3.,5%%

(*%A+P%.,3%.%2P,,3):%2P4:+-3,%,34@+)41T03%*+,%-P0@03%41:34%.)/%V+P0/%01Q3%:+%:.Q3%./G.):.>3%+*%:I14%43,G123\%@03.43%2.00%!"#$%&'%

?P4:+-3,%"3,G123%.:%EKK7;B673%J%+*%:I3%9),+00-3):%O+,-5

9),+00-3):%?+)!,-.+)%?+@134% % % % [+%.//1+).0%2+4:'34)>% 41:34% .,3% 3b@32:3/% :+% Q33@% 3),+00-3):% 2+)!,-.+)% ,32+,/4% +)% 41:3% *+,% .:% 03.4:% :V+% A3.,45% $+V3G3,\% -.).>3,4% .)/%

2+)4P0:.):4%P4P.00A%I.G3%,34@+)41T101:A%*+,%+,>.)1N1)>%/+2P-3):. +)%@,1+,%:+%.22,3/1:.+)%1)4@32+)45%%LA%2I32Q1)>%:I3%*?9:22,

&:?!9@,&:8C,+@+)\%2+@134%+*%:I3%3),+00-3):%2+)!,-.+)%*+,-4%W1)20P/1)>%41:374@321!2%4I1@-3):%42I3/P034Y%.,3%@,+G1/3/%:+%

.4414:%A+P%V1:I%:I14%:.4Q5%%F.)A%2+)4P0:.):4%,3231G1)>%:I14%43,G123%!)/%1:%.04+%e20+434%:I3%+,/3,1)>%0++@f%.)/%.44P,34%:I.:%:I3%

@P,2I.41)>%/3@.,:-3):%I.4%4PT-13/%.00%+,/3,4%.)/%V3%I.G3%2+,,32:0A%@,+23443/%:I3-5%%'I14%43,G123%14%+3,3/%.:%)+%2I.,>35

`P.01:A%F.).>3-3):%U3@+,:%W`FUY% % % % @7=2;%&'E8KKK%%F9D'2;%p;KK9G3,A%:I,33%-+):I4% A+P%V100%,3231G3%.)% 3032:,+)12%,3@+,:%W9b230%!03%*+,-.:Y%2+):.1)1)>%.00%&'%:34)>%1)*+,-.+)%*+,%A+P,%41:34%

2+G3,1)>%:I3%-+4:%,323):%:V+%A3.,4%W?P,,3):%2P4:+-3,4%V100%I.G3%:I31,%/.:.%@,37@+@P0.:3/%1):+%:I31,%!,4:%,3@+,:Y5

'I3%,3@+,:%V100%T3%43):%:+%A+P,%3-.10%.//,344%.)/%2+-34%@,374+,:3/%1):+%*+P,%2.:3>+,134Z

% "I33:%lJ%r%.00%&'%:34)>%/.:.%4+,:3/%TA%!"#$%&'%2P4:+-3,%)P-T3,%

% "I33:%l6%r%.).0A:34%TA%41:3XA3.,X3G3):%V1:I%P).223@:.T03%42+,34

% "I33:%l8%r%.).0A:34%TA%41:3XA3.,X3G3):%V1:I%.223@:.T03%42+,34%TP:%0344%:I.)%JKKs

% "I33:%l;%r%.).0A:34%,3231G1)>%JKKs%*+,%t[+)72+)43)4P4t\%t[+:%"2+,3/t%+,%t9b2P43%U3]P34:3/t%41:P.+)4

"2+,1)>%/3:.104%4P2I%.4%e#.:3f%+,%e[+%,34P0:4%,3231G3/f%V100%T3%1)20P/3/%1)%:I3%,3@+,:%:+%I30@%A+P%1/3) *A%.)/%/+2P-3):%:I3%,3.4+)4%

*+,%0344%:I.)%4.4*.2:+,A%@3,*+,-.)235

?+):.2:%EKK7;B6703%+)7/3-.)/%,3@+,:%2+):.1)1)>%:V+%A3.,4%+*%!"#$%&'%/.:.%@,+G1/3/%1)%:I3%4.-3%*+,-.:%014:3/%*+,%:I3%`FU%.T+G35%%U3@+,:%

14%1):3)/3/%:+%.4414:%1)%@,3@.,.+)%*+,%.)%+)741:3%4P,G3A5%%'I3%,3@+,:%2.)%T3%@,3@.,3/%*+,%41)>03%+,%-P0@03%41:34%[email protected]%@,+G1/3%.%

014:%+*%"#l4%VI3)%+,/3,1)>Y5%%?+):.2:%EKK7;B67


10/44


!*

,7*01'.

See page 4 for Product Type information

Analytes listed in black are regulated under CLIA 8

Electrolytes / Metabolites (Waived Methods) (BGW)

LH922/EHDC?268E/C29/M2&9//+//NDO2/E&?C%2E/C29/EHDC?268/

F97=>'8/P6Q79?&8D76;//8-#%4.-@034%4P1:.T03%*+,%T0++/%>.4%.)/X+,%.]P3+P4%2I3-14:,A%:34)>5%%".-@034%.,3%[email protected]%V1:I%-+4:%T0++/%>.4%1)4:,P-3):4%1)20P/1)>%%D-E,56C79E,*1(&E,/-E,!"#$%$E,/$&E,/+)%E,)7;!%*+,%+)3%43:%+*%,34P0:45%%?.)%+)0A%T3%+,/3,3/%1)%2+)dP)2+)%V1:I%.%LM%T.43%@,+/P2:5

R6&%M82E;$3-+>0+T1)% % % $3-.:+2,1:

Blood Gas Hemoglobin / Hematocrit - Add-on to BG

LH922/EHDC?268E/C29/M2&9//+//NDO2/E&?C%2E/C29/EHDC?268

F97=>'8/P6Q79?&8D76;//6-#%4.-@034%+*%4:.T101N3/%I3-+>0+T1)%4+0P+)5

R6&%M82E;?.,T+bAI3-+>0+T1)% % F3:I3-+>0+T1)

$3-+>0+T1)\%:+:.0% % =bAI3-+>0+T1)

Co-oximetry (CO)

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2:%7%J7'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

S//7+)%@,+/P2:%7%LM$ &'JKJK8 p;6

S//1:1+).0%4.-@034 &'JKJKJ p8H

S//7+)%@,+/P2:%7%LM$[ &'JKJJ8 p;6

S//1:1+).0%4.-@034 &'JKJJJ p8H

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'JK6KK p6H;S//1+).0%4.-@034 &'JK6KJ p &'JK6K6 pB8

LS7/EHDC?268E/C29/M2&9//+//LH922/E&?C%2E/C29/EHDC?268/

F97=>'8/P6Q79?&8D76;//8-#%4.-@034%4P1:.T03%*+,%.]P3+P4%2I3-14:,A%:34:1)>5%():3)/3/%*+,%V.1G3/%4A4:3-4%4P2I%.4%!"#$%$,F%P41)>%.),!"#$%$,&976E,&G*)HI \%+,%+:I3,%V.1G3/%2.,:,1/>35%%#.T+,.:+,134%P41)>%)+)7V.1G3/%-3:I+/4%4I+P0/%,3*3,%:+%L0++/%M.434%@,+/P2:%014:3/%.T+G35

R6&%M82E;?.,T+)%/1+b1/3\%:+:.0% % (+)1N3/%2.021P-?I0+,1/3% % % &+:.441P-?,3.)1)3% % % "+/1P-M0P2+43% % % R,3.%)1:,+>3)

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'JK8KK pJBK

S//1+).0%4.-@034 &'JK8KJ p8K

S//1:1+).0%,34P0:%,3@+,:1)> &'JK8K6 p


11/44


!!See page 4 for Product Type information.

Analytes listed in black are regulated under CLIA 88. ** Not accepted by the CAP Laboratory Accreditation Program, see page 5 for more information.


F97=>'8/P6Q79?&8D76;//+b1)% % % % %%'IA,+1/74-P0.)>%I+,-+)3%W'"$YO,33%:IA,+b1)3%WO'

;Y% % % %%'IA,+b1)3%W'

;Y

O,33%:,11+/+:IA,+)1)3%WO'8Y% % %%'+T,.-A21)

M.--.%>0P:.-A0:,.)4*3,.43%WMM'Y% %%',1>0A23,1/34M3):.-121)% % % % %%',11+/+:IA,+)1)3%W'

8Y

M0P2+43% % % % %%R,3.%)1:,+>3)%WLR[YI?M\%]P.):.G3%W43,P-Y% % %%R,12%.21/(,+)%T1)/1)>%[email protected]:A%W'(L?Y\%2.02P0.:3/% %%D.0@,+12%.21/(,+)%T1)/1)>%[email protected]:A%W'(L?Y\%-3.4P,3/% %%D.)2+-A21)

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2:4

U3@+,)>%J7B%.).0A:34 &'JJKKK pJ%C7JJ%.).0A:34 &'JJKJK pJCJ

U3@+,)>%J67JB%.).0A:34 &'JJK6K p66E

U3@+,)>%JC76J%.).0A:34 &'JJK8K p6C8

U3@+,)>%6676B%.).0A:34 &'JJK;K p8K8

U3@+,)>%6C78K%.).0A:34 &'JJK3):%>,./3%V.:3,%.,3%,32+--3)/3/%*+,%,32+)4:P+)5

S//7+)%@,+/P2:%1)20P/34%+)3%43:%+*%4.-@034%.)/%,3@+,:1)>%*+,%+)3%43:%+*%,34P0:4%.)/%2.)%+)0A%T3%+,/3,3/%1)%2+)dP)2+)%V1:I%.%?9'%T.43%@,+/P2:5

R6&%M82E;'(L?%W2.02P0.:3/Y% '(L?%W-3.4P,3/Y% % R(L?%W-3.4P,3/Yvv

UIBC / TIBC (IBC)

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'JJJKK pHK

S//7+)%@,+/P2:%W:+%?9'Y &'JJJK8 p8K

LH922/EHDC?268E/C29/M2&9//+//NDO2/E&?C%2E/C29/EHDC?268F97=>'8/P6Q79?&8D76;//J-#%01]P1/%4.-@0345

S//7+)%@,+/P2:%1)20P/34%+)3%43:%+*%4.-@034%.)/%,3@+,:1)>%*+,%+)3%43:%+*%,34P0:4%.)/%2.)%+)0A%T3%+,/3,3/%1)%2+)dP)2+)%V1:I%.%?9'%T.43%@,+/P2:5

R6&%M82;I?M\%]P.01:.G3%W43,P-Y

hCG, serum (HCG)

B9=29/BC8D76EF97=>'8/LMC2 F97=>'8/

@7=2R66>&%/

F9D'2

L.43%@,+/P2: &'JJ6KK pJ86

S//1+).0%4.-@034 &'JJ6KJ p8B

S//1:1+).0%,34P0:%,3@+,:1)> &'JJ6K6 p;6

S//7+)%@,+/P2:%W:+%?9'Y &'JJ6K8 pB8

@7=2E/Q79/R==D8D76&%/J&?C%2E/&6=/T2E>%8/T2C798D6U

l%+*%.).0A:34

S//1:1+).0%4.-@034

S//1:1+).0%,34P0:4

J7B &'JJKKJ &'JJKK6

C7JJ &'JJKJJ &'JJKJ6

67JB &'JJK6J &'JJK66

JC76J &'JJK8J &'JJK86

6676B &'JJK;J &'JJK;6

6C78K &'JJK


12/44


!"

,7*01'.



B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'J6KKK p6'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'J6JKK pJ;;

S//1+).0%4.-@034 &'J6JKJ p &'J6JK6 p8B

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'J66KK pJEHS//1+).0%4.-@034 &'J66KJ pBK

S//1:1+).0%,34P0:%,3@+,:1)> &'J66K6 pBK

LS7/EHDC?268E/C29/M2&9//+//LH922/E&?C%2E/C29/EHDC?268

F97=>'8/P6Q79?&8D76;//%V.1G3/%-3:I+/4%4P2I%.4%:I3%%J6K!4,1!'8/P6Q79?&8D76;//6-#%01]P1/%4.-@0345R6&%M82;

S--+)1.

Ammonia (NH)


F97=>'8/P6Q79?&8D76;//J-#%01]P1/%4.-@034%2+):.1)1)>%303G.:3/%03G304%+*%T101,PT1)%41-10.,%:+%:I+43%*+P)/%1)%)3+).:34%.)/%01G3,%/143.435

R6&%M82E;

L101,PT1)\%:+:.0%% %L101,PT1)\%/1,32:L101,PT1)\%+:I3,%*,.2+)4%W01-1:3/%1)4:,P-3):4Y

Elevated Bilirubin (NB)

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2:%7%J7E%.).0A:34 &'JJ8KK pJ &'JJ8J6 pCK


13/44


!#

See page 4 for Product Type information.

Analytes listed in black are regulated under CLIA 88. ** Not accepted by the CAP Laboratory Accreditation Program, see page 5 for more information.


F97=>'8/P6Q79?&8D76;//#A+@I101N3/%43,P-%4.-@0345%%S%65K-#%20.44%S%G+0P-3:,12%@1@33%.)/%,3.>3):%>,./3%V.:3,%.,3%,32+--3)/3/%*+,%,32+)4:P+)5%

R6&%M82E;?7@3@/3vv% % &'$()4P01)vv% % 6'8/P6Q79?&8D76;//6-#%VI+03%T0++/%4.-@0345%%$3-.:+2,1:%@,+G1/3/5%

R6&%M82;U3/%2300%*+0.:3

RBC Folate (FR)


F97=>'8/P6Q79?&8D76;//'8/P6Q79?&8D76;//6-#%01]P1/%4.-@0345

R6&%M82E;?S%J63)12%3-T,A+)12%.)>3)%W?9SY?S%J3)\%*,33%W*,33%&"SY?S%JH7Hvv% &,+4:.:3%4@321!2%.)>3)\%:+:.0%W&"SY

Tumor Markers (MT)

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'J68KK pJ;;

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'J6'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'J6BKK pJBK

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2:%7%J7 &'J6;K6 pBE

L.43%@,+/P2:%7%Bu%.).0A:34 &'J6;JK pJC6

S//1+).0%4.-@034 &'J6;JJ p;6

S//1:1+).0%,34P0:%,3@+,:1)> &'J6;J6 pBE

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2:%7%J78%.).0A:34 &'J6CKK pJBK

S//1+).0%4.-@034 &'J6CKJ pBK

S//1:1+).0%,34P0:%,3@+,:1)> &'J6CK6 p &'J6CJ6 p


14/44


!,

,7*01'.


Analytes listed in black are regulated under CLIA 88. ** Not accepted by the CAP Laboratory Accreditation Program, see page 5 for more information


F97=>'8/P6Q79?&8D76;//#1]P1/%4.-@034%1):3)/3/%:+%41-P0.:3%@03P,.0\%@3,1:+)3.0\%.)/%-142300.)3+P4%T+/A%"P1/4%W+:I3,%:I.)%?"O%+,%P,1)3Y5

R6&%M82E;% %S0TP-1)% % ?,3.)1)3% @$S-A0.43% % M0P2+43% % &,+:31)?I+034:3,+0% % #^% % ',1>0A23,1/34

Body Fluid Chemistry (PC)


F97=>'8/P6Q79?&8D76;//#1]P1/%4.-@0345

R6&%M82E;?I0+,1/3% % #^% % "+/1P-M0P2+43% % &+:.441P-#.22%.21/% % &,+:31)

Spinal Fluid Chemistry (SF)

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'J8KKK pJCE

S//1+).0%4.-@034 &'J8KKJ p;K

S//1:1+).0%,34P0:%,3@+,:1)> &'J8KK6 pBB

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'J8JKK p66K

S//1+).0%4.-@034 &'J8JKJ p;K

S//1:1+).0%,34P0:%,3@+,:1)> &'J8JK6 pBB


F97=>'8/P6Q79?&8D76;//#1]P1/%4.-@0345%%'I343%4.-@034%.,3%)+:%2+-@.:1T03%V1:I%:I3%%P!?!:?%.).0AN3,5

R6&%M82E;SX?%,.+\%]P.):.G3% % F12,+.0TP-1)\%]P.):.G3SX?%,.+\%43-17]P.):.G3% F12,+.0TP-1)\%43-17]P.):.G3S-A0.43% % % =4-+0.01:A?.021P-% % % &I+4@I+,P4?I0+,1/3% % % &+:.441P-?,3.)1)3\%]P.):.G3% &,+:31)?,3.)1)3\%43-17]P.):.G3% "+/1P-M0P2+43% % % R,3.%[1:,+>3)F.>)341P-% % % R,12%.21/

F12,+.0TP-1)\%]P.01:.

G3%

Urine Chemistry (CU)

LH922/EHDC?268E/C29/M2&9//+//LS7/E&?C%2E/C29/EHDC?268

F97=>'8/P6Q79?&8D76;// JK-#%4.-@034%1):3)/3/%*+,%:I3%]P.01:.G3%/3:32+)%+*%/,P>4%P41)>%P,1)3%1--P)+.44.A%42,33)1)>%@,+23/P,345

R6&%M82E;/S23:.-1)+@I3)% % F^FS%W924:.4AYS-@I3:.-1)34% % F3:I./+)3L.,T1:P,.:34% % % F3:I.-@I3:.-1)34L3)N+/1.N3@1)34% % F3:I.]P.0+)3LP@,3)+,@I1)3vv% % F+,@I1)3?.)).T1)+1/4%W'$?Y% % =@1.:34?+2.1)3%F3:.T+01:34% % =bA2+/+)39^^&vv% % % &I3)2A201/1)3%W&?&Y9:I.)+0%WS02+I+0Y% % &,+@+bA@I3)3#"^vv% % % ',12A2012%.)/3@,344.):4

Urine Drug Screen (UD)

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'J88KK p6KC

S//1+).0%4.-@034 &'J88KJ p;E

S//1:1+).0%,34P0:%,3@+,:1)> &'J88K6 pBK

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2:%7%J78%.).0A:34 &'J86KK pJ &'J86J6 pC6

L.43%@,+/P2:%7%JJu%.).0A:34 &'J866K p6;B

S//1+).0%4.-@034 &'J866J p;K

S//1:1+).0%,34P0:%,3@+,:1)> &'J8666 pC6


15/44


!.

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'J;KKK p8HK

S//1:1+).0%,34P0:%,3@+,:1)> &'J;KK6 p8B

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'J;KJK p6KK

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/

@7=2

R66>&%/

F9D'2L.43%@,+/P2: &'J;JKK pJBK

S//1+).0%4.-@034 &'J;JKJ p;K

S//1:1+).0%,34P0:%,3@+,:1)> &'J;JK6 p;K

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'J;JJK pJBK

S//1

+).0%4.-@034 &'J;JJJ p;KS//1:1+).0%,34P0:%,3@+,:1)> &'J;JJ6 p;K


Analytes listed in black are regulated under CLIA 88.


F97=>'8/ P6Q79?&8D76;/ / J-#%VI+03% T0++/%4.-@0345%% 'I343%4.-@034%.,3%)+:%[email protected]%V1:I%%!?!:?,%#FQQ5

R6&%M82;$3-+>0+T1)%SJ2

Glycohemoglobin (GH)


F97=>'8/P6Q79?&8D76;//K50+T1)%SJ2

Glycohemoglobin Afinion AS100(GHA)


F97=>'8/P6Q79?&8D76;//!I+03%T0++/%4.-@0345%():3)/3/%*+,%V.1G3/%-3:I+/45

R6&%M82;L0++/%03./

Blood Lead QA (BL)


F97=>'8/P6Q79?&8D76;//!I+03%T0++/%4.-@0345%

R6&%M82;L0++/%03./

Blood Lead Reg (PB)


16/44


!-

,7*01'.



B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'J;;KK pJ6E

LS7/EHDC?268E/C29/M2&9//+//NDO2/E&?C%2E/C29/E28/C29/EHDC?268

F97=>'8/P6Q79?&8D76;// 6-#%VI+03%T0++/%4.-@034%1):3)/3/%*+,% V.1G3/%>0P2+43%-3:3,45% %".-@034%.,3%2+-@.:1T03%V1:I%-+4:%T0++/%>0P2+43%-3:3,4%P43/%*+,%.)2100.,AX@+1):%+*%2.,3%:34:1)>5%%".-@034%)+:%2+-@.:1T03%V1:I%G7@:&375

=,/3,%T.43%@,+/P2:%.22+,/1)>%:+%)P-T3,%+*%,34P0:%43:4%,3@+,:3/5%%S//1 +).0%4.-@034%@,+/P2:%1)20P/34%+)0A%+)3%43:%+*%4.-@0345

U34P0:%"3:4% L.43%@,+/P2:%1)20P/34% J76K% J%43:%+*%4.-@034

% 6J7;K% 6%43:4%+*%4.-@034

% ;J7BK% 8%43:4%+*%4.-@034

% BJ7EK% ;%43:4%+*%4.-@034

R6&%M82;!I+03%L0++/%M0P2+43%WV.1G3/Y

Whole Blood Glucose 5 Samples (WB)

LS7/EHDC?268E/C29/M2&9//+//LH922/E&?C%2E/C29/E28/C29/EHDC?268

F97=>'8/P6Q79?&8D76;//6-#%VI+03%T0++/%4.-@034%1):3)/3/%*+,%V.1G3/%>0P2+43%-3:3,45%%".-@034%.,3%2+-@.:1T03%V1:I%-+4:%T0++/%>0P2+43%-3:3,4%P43/%*+,%.)2100.,AX@+1):%+*%2.,3%:34:1)>5%%".-@034%)+:%2+-@.:1T03%V1:I%G7@:&375

=,/3,%T.43%@,+/P2:%.22+,/1)>%:+%)P-T3,%+*%,34P0:%43:4%,3@+,:3/5%%S//1+).0%4.-@034%@,+/P2:%1)20P/34%+)0A%+)3%43:%+*%4.-@0345

U34P0:%"3:4% L.43%@,+/P2:%1)20P/34% J76K% J%43:%+*%4.-@034

% 6J7;K% 6%43:4%+*%4.-@034

% ;J7BK% 8%43:4%+*%4.-@034

% BJ7EK% ;%43:4%+*%4.-@034

R6&%M82;!I+03%L0++/%M0P2+43%WV.1G3/Y

Whole Blood Glucose 3 Samples (SW)

LS7/EHDC?268E/C29/M2&9//+//LH922/E&?C%2E/C29/EHDC?268F97=>'8/P6Q79?&8D76;//J-#%VI+03%T0++/%4.-@034%.)/%,3@+,)>%*+,%P@%:+%&%/F9D'2

L.43%@,+/P2:4

J76K%,34P0:%43:4 &'J;6KK p6KK

6J7;K%,34P0:%43:4 &'J;6JK p8C;;J7BK%,34P0:%43:4 &'J;66K p'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2:4

J76K%,34P0:%43:4 &'J;8KK pJ8;

6J7;K%,34P0:%43:4 &'J;8JK p6;B

;J7BK%,34P0:%43:4 &'J;86K p8


17/44


!A

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'J&%/F9D'2

L.43%@,+/P2: &'J&%/

F9D'2

L.43%@,+/P2: &'J&%/F9D'2

L.43%@,+/P2: &'J0+T1)% ',+@+)1)%'

Cardiac Markers 5 Samples (IE)


F97=>'8/P6Q79?&8D76;// 6-#%01]P1/%4.-@0345%%?+-@.:1T03%V1:I%!"#$%$5%%?U&%-3:I+/4%P43/%:+%42,33)%*+,%)+)74@321*12%1)*0.--.:+,A%/143.43%4I+P0/%+,/3,%(--P)+43,+0+>A7?U&%+)%@.>3%6%+)0A%/7/1-3,%4I+P0/%+,/3,%^7/1-3,7',1.>3%+)%@.>3%JH5

R6&%M82E;L[&% % /7/1-3,% % ',+@+)1)%(?o7FL% FA+>0+T1)% %

Cardiac Assessment Triage (CP)


F97=>'8/P6Q79?&8D76;// J-#%9^'S%@0.4-.%4.-@034%2+-@.:1T03%V1:I%.P:+-.:3/%-3:I+/4%1)20P/1)>%%JJ:==E,57


18/44


!)

(42@41*(-

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'6KKKK pJ;C

S//1+).0%4.-@034 &'6KKKJ p &'6KKK6 pBK

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2:%7%&U? &'6KJKK p68J

S//1+).0%4.-@034 &'6KJKJ pJ &'6KJK6 p;E

L.43%@,+/P2:%7%&_" &'6KJJK p6JH

S//1+).0%4.-@034 &'6KJJJ pHB

S//1:1+).0%,34P0:%,3@+,:1)> &'6KJJ6 p;E

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'6K6KK pJ8K

S//1+).0%4.-@034 &'6K6KJ pBB

S//1:1+).0%,34P0:%,3@+,:1)> &'6K6K6 p;E

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'6K6JK pJ6K

S//1+).0%4.-@034 &'6K6JJ pBB

S//1:1+).0%,34P0:%,3@+,:1)> &'6K6J6 p;E



INR (Waived Method) CoaguChek XS (CXSW)


F97=>'8/P6Q79?&8D76;//#A+@I101N3/%@0.4-.%4.-@0345%%S%J5K-#%20.44%S%G+0P-3:,12%@1@3::3%.)/%,3.>3):%>,./3%V.:3,%.,3%,32+--3)/3/%*+,%,32+)4:1:P:1+)5%%'I343%4.-@034%.,3%[='%2+-@.:1T03%V1:I%VI+03%T0++/%1)4:,P-3):4%X%4A4:3-4%4P2I%.4%17#$%$E,/$&E,&:6A3&L7OE,+,,&:6A3#7?475

R6&%M82E;S2:1G.:3/%@.,:1.0%:I,[email protected]:1)%:1-3%WS&''Y

O1T,1)+>3)&,+:1-3%W&'Y([U

Coagulation Basic (CA)


F97=>'8/P6Q79?&8D76;//():3)/3/%*+,%)+)7V.1G3/%4A4:3-45%%".-@034%1)%3.2I%T.43%@,+/P2:%.)/%.//1:1+).0%4.-@034%@,+/P2:%.,3%1)4:,P-3):%4@321*125

% ".-@034% [email protected]%V1:I

% &U?% %!"#$%$,6?;,&:6A3#7?47,1)4:,P-3):4

% &_"% &:6A3&L7O,N#,"A4:3-4%W&0P4\%&,+\%_"Y

R6&%M82E;

&,+:1-3([U

Protime / INR (Whole Blood)


F97=>'8/P6Q79?&8D76;// ".-@034%1):3)/3/%*+,%/$&,19:$!@7,)!


19/44


!K

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'6K;KK pJ6;

S//1+).0%4.-@034 &'6K;KJ p &'6K;K6 p;E

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'6K;JK pJ8K

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'6K;6K pJ8B

S//1+).0%4.-@034 &'6K;6J pEB

S//1:1+).0%,34P0:%,3@+,:1)> &'6K;66 p;E




F97=>'8/P6Q79?&8D76;/// L.43%@,+/P2:%.)/%.//1:1+).0%4.-@03%@,+/P2:%Q1:%3.2I%@,+G1/3%:I,33%0A+@I101N3/%4.-@034%V1:I%/10P3):%.)/%.%2.021P-%2I0+,1/3%4+0P:1+)%W.2:1G.:+,Y5%%S//1:1+).0%4.-@034%W+)0AY%1)20P/34%4.-@034%V1:I%/10P3):%.)/%)+%?.?05%%&,+/P2:4%.,3%1)4:,P-3):%4@321*125

% ".-@034% [email protected]%V1:I% ?'L% /$&,G*)(&G+(0,4C4=7@4E,/-,.*),1&-E,G727?6,%'8/P6Q79?&8D76;//#A+@I101N3/%@0.4-.%4.-@034%2+-@.:1T03%V1:I%-+4:%/7/1-3,%Q1:4%1)20P/1)>% #C4@7K,&%,.)/%#!@82!PC%VI3,3%@.:13):%@0.4-.%14%:34:3/5%%[+:%

1):3)/3/%*+,%!"#$%$E,#!@82!+7;E,+,,#!@82!PC,STL:27,J2::;U5R6&%M82;

/7/1-3,\%]P.01:.:1G3% % /7/1-3,\%]P.):1:.:1G3

D-dimer Plasma (DD)


F97=>'8/P6Q79?&8D76;//#A+@I101N3/%@0.4-.%4.-@034%.)/%.%G1.0%+*%V.4I3/%UL?%/10P3):5%?+-@.:1T03%V1:I%#!@82!+7;R%%S04+%2+-@.:1T03%V1:I%#!@82!PC%VI3)%@.:13):%VI+03%T0++/%14%:34:3/5

R6&%M82;/7/1-3,\%]P.01:.:1G3

D-dimer Whole Blood (DR)


F97=>'8/P6Q79?&8D76;//".-@034%2I.003)>3%.%/1**3,3):%,34P0:%,.)>3%:I.)%^^\%^U%.)/%?&%@,+/P2:45%%(*%P41)>%.%$9!6A7%:34:%/3G123X2.,:,1/>3%:I.:%,3@+,:4%-+,3%:I.)%/7/1-3,\%+,/3,%?.,/1.2%S44344-3):7 $9!6A7%+)%@.>3%JC5

R6&%M82;/7/1-3,\%]P.):1:.:1G3

D-dimer Triage (DT)

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2:%7%?'L &'6K8KK p6JE

S//1+).0%4.-@03%Q1: &'6K8KJ pB6

S//1+).0%4.-@034%W+)0AY &'6K8EJ p &'6K8K6 p;K

L.43%@,+/P2:%7%?'= &'6K8JK p6JE

S//1+).0%4.-@03%Q1: &'6K8JJ pB6

S//1+).0%4.-@034%W+)0AY &'6K8HJ p &'6K8J6 p;K


20/44


"*

,741((2.

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'6JKKK p6KC

S//1:1+).0%,34P0:%,3@+,:1)> &'6JKK6 pBB



B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2:%7%S' &'6JJKK p68C

S//1:1+).0%,34P0:%,3@+,:1)> &'6JJK6 pBB

L.43%@,+/P2:%7%S" &'6JJJK p68CS//1:1+).0%,34P0:%,3@+,:1)> &'6JJJ6 pBB


F97=>'8/P6Q79?&8D76;// !I+03%T0++/%4.-@034%V1:I%@13,23.T03%2.@4%*+,%-.)P.0%+,%.P:+-.:3/%-3:I+/45%%

?+-@.:1T03%V1:I%

%JJ:==,&722"MC?,FVQQE,FWQQE,FXQQE,FHQQE,*@7962;Y,%5N,)!


21/44


"!

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'6J;KK pJ66

S//1+).0%4.-@034 &'6J;KJ p &'6J;K6 p;K

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'66KKK p6KK

S//1+).0%4.-@034 &'66KKJ p;E

S//1:1+).0%,34P0:%,3@+,:1)> &'66KK6 p;K

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'666KK pJ'8/P6Q79?&8D76;// #1]P1/%VI+03%T0++/%4.-@034%2+-@.:1T03%V1:I%G7@:&37,G7@:A2:J!?,#C4=7@4E,/$&,GAJ,19:E,#$%$"#!=7,)E,#83?,L7@6=:'8/P6Q79?&8D76;//":.T101N3/%UL?%4.-@0345

R6&%M82;"12Q03%2300%42,33)

Sickle Cell Screen (SK)

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2:%7%"U &'66JKK pJ &'66JK6 p;K

L.43%&,+/P2:%7%"US &'66JJK pJ &'66JJ6 p;K


22/44


""

=+'(0+(;.

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'8KKKK p66;

S//1+).0%4.-@034 &'8KKKJ pJ;K

S//1:1+).0%,34P0:%,3@+,:1)> &'8KKK6 p;K

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2:4

SP:+-.:3/%2+P):%WLOSY &'8KJKK pJHK

F.)P.0%2300%2+P):%WLOFY &'8KJJK pJEK

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'8K6KK p;6

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'8K8KK pJJE

S//1+).0%4.-@034 &'8K8KJ p8K

S//1:1+).0%,34P0:%,3@+,:1)> &'8K8K6 p8K

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'8K;KK pJ6E

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'8K%4@1).0%.)/X+,%4A)+G1.0%*0P1/%.).0A4145

R6&%M82E;?300%1/3):1*12.:1+)% ?,A4:.0%1/3):1*12.:1+)

Body Fluid Microscopy (BF)

LS7/EHDC?268E/C29/M2&9//+//LH922/'H&%%26U2E/C29/EHDC?268

F97=>'8/P6Q79?&8D76;// K5.4:,12%+22P0:%T0++/%.)/%.-)1+:12XT+/A%*0P1/%@$%-3.4P,3-3):5%%

@$%14%2+-@.:1T03%V1:I%[1:,.N1)3%.)/%01:-P4%@.@3,%:34:1)>5

R6&%M82E;@$% % % =22P0:%T0++/

Body Fluid pH/Occult Blood (GO)


F97=>'8/P6Q79?&8D76;//?03.,\%@,+:31)7T.43/%4.-@034%1):3)/3/%*+,%0.T4%@3,*+,-1)>%4@1).0%.)/X+,%4A)+G1.0%*0P1/%2300%2+P):4%TA%.P:+-.:3/%+,%-.)P.0%-3:I+/45

R6&%M82E;U3/%T0++/%2300%2+P):% !I1:3%T0++/%2300%2+P):

Body Fluid Cell Count


F97=>'8/P6Q79?&8D76;//'8/P6Q79?&8D76;//".-@034%*+,%/3:32:1)>%:I3%@,343)23X.T43)23%+*%*0P1/%*,+-%,P@:P,3/%*3:.0%-3-T,.)345%%():3)/3/%*+,%P43%V1:I%:I3%%@?!4397,+()%Q1:%+)0A5

R6&%M82;&SFM7J%@,+:31)

Amniotic Fluid Detection Amnisure ROM(AE)


F97=>'8/P6Q79?&8D76;//?+-@.:1T03%V1:I%:I3,-*'^("$*#$E,-*'^(,*_,D'*E,/5M,&L7OE,.)/,/5M,*_,D'*,-3:I+/45

F97'2=>92;#.2:+*3,,1)

Fecal Lactoferrin (LF)


23/44


"#

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'8KBKK p8KK

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'8KCKK pJ'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'8JJKK pJ8E

S//1+).0%4.-@034 &'8JJKJ p;K

S//1:1+).0%,34P0:%,3@+,:1)> &'8JJK6 p;K

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/

@7=2

R66>&%/

F9D'2L.43%@,+/P2: &'8J6KK p;6

S//1+).0%4.-@034 &'8J6KJ pJK

S//1:1+).0%,34P0:%,3@+,:1)> &'8J6K6 p6;



LS7/EHDC?268E/C29/M2&9//+//LS7/'H&%%26U2E/C29/C97'2=>92

F97=>'8/P6Q79?&8D76;//'V+%@I+:+%2+-@+41:34%+*%3.2I%+*%:I3%@,+23/P,34%014:3/%T30+V5%%U3@+,:%+)0A%:I+43%@,+23/P,34%@3,*+,-3/5%%&'&0P4%+)01)3%&&F%?+-@3:3)2A%.04+%.G.10.T03%+)%@.>3%B5

F97'2=>92E;O32.0%4-3.,%*+,%03PQ+2A:34% &1)V+,-%@,3@.,.:1+)O3,)%:34:% % % R,1)3%43/1-3):o=$%@,3@.,.:1+)% % D.>1).0%V3:%@,3@.,.:1+)[.4.0%4-3.,%*+,%3+41)+@I104

Provider Performed Microscopy (PM)


F97=>'8/P6Q79?&8D76;//J-#%01]P1/%41-P0.:3/%23,G12+7G.>1).0%4.-@0345

R6&%M82E;O3:.0%*1T,+)32:1)

Fetal Fibronectin (FFN)

LS7/EHDC?268E/C29/M2&9//+//NDO2/E&?C%2E/C29/EHDC?268F97=>'8/P6Q79?&8D76;//#1]P1/%4.-@034%*+,%P,1)3%@,3>).)2A5

R6&%M82;R,1)3%I?M%r%]P.01:.:1G3%WV.1G3/Y

Urine hCG 5 Samples (UH)

LS7/EHDC?268E/C29/M2&9//+//LS7/'H&%%26U2E/C29/EHDC?268

F97=>'8/P6Q79?&8D76;//S%@I+:+%2+-@+41:3%+*%:V+%P,1)3%43/1-3):%2+-@+)3):45

F97'2=>92;R,1)3%43/1-3):%2+-@+)3):%1/3):1*12.:1+)%TA%-12,+42+@3

Urine Sediment Identification (SU)

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'8JKKK pJK;

S//1+).0%4.-@034 &'8JKKJ p8B

S//1:1+).0%,34P0:%,3@+,:1)> &'8JKK6 p'8/P6Q79?&8D76;// #1]P1/%4.-@034%*+,%P,1).0A414%.)/% P,1)3% @,3>).)2A5%?,3.:1)1)3%14%*+,%/1@4:12Q%-3:I+/%+)0A%W,3*3,%:+%R,1)3%?I3-14:,A%+)%@.>3%J;%*+,%+:I3,%-3:I+/4Y5%%"3,P-%I?M%433%@.>3%JJ5

R6&%M82E;% %L101,PT1)% % % o3:+)34% % % &,+:31)?,3.:1)1)3\%43-17]P.):1:.:1G3% #3PQ+2A:3%34:3,.43% "@321*12%>,.G1:AM0P2+43% % % [1:,1:3% % % R,+T101)+>3)$3-+>0+T1)XL0++/% % @$

?+)*1,-.:+,A%'34:1)>% % R,1)3%I?MS23:34:% % % R,1)3%I?M%r%]P.01:.:1G3%WV.1G3/Y(2:+:34:U3/P21)>%4PT4:.)234

Urinalysis / Urine hCG (UR)


24/44


",

,7,-

-4.*0

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'86KKK p6;K

S//1+).0%4.-@034 &'86KKJ pJ8K

S//1:1+).0%,34P0:%,3@+,:1)> &'86KK6 p8K

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'86JKK p6;K

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2:4

R)4:.1)3/%401/3%W"FY &'866KK p6;K

&,374:.1)3/%401/3%W"F"Y &'866JK p6;K

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'868KK p6BK

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'86;KK p6;K



LS7/EHDC?268E/C29/M2&9//+//LS7/E&?C%2E/C29/EHDC?268

F97=>'8/P6Q79?&8D76;//K56-#%4:.T101N3/%IP-.)%4@3,-%4.-@034%.@@,+@,1.:3%*+,%@+4:7G.432:+-A%42,33)1)>5

F97'2=>92;"@3,-%2+P):\%]P.01:.:1G3

Post-Vasectomy Semen Analysis (PV)

LS7/EHDC?268E/C29/M2&9//+//LS7/E&?C%2E/C29/EHDC?268

F97=>'8/P6Q79?&8D76;//K56-#%4:.T101N3/%01]P1/%4.-@0345

F97'2=>92;"@3,-%2+P):\%]P.):1:.:1G3

Sperm Count (SP)

LS7/EHDC?268E/C29/M2&9//+//B62/E%D=2/&6=/CH787U9&CH/C29/EHDC?268

F97=>'8/P6Q79?&8D76;//=,/3,%T.43%@,+/P2:%TA%401/35%%&,374:.1)3/%401/3%14%1):3)/3/%*+,%G3@6A7?`,$74=4!@827=4

F97'2=>92;"@3,-%-+,@I+0+>A

Sperm Morphology

LS7/EHDC?268E/C29/M2&9//+//B62/@1+T7?/C29/EHDC?268

F97=>'8/P6Q79?&8D76;// S%?^7U+-%V1:I%G1/3+4%+*%:V+%43-3)%4.-@0345%%D1/3+4%2+):.1)%-P0:1@03%-12,+42+@12%*130/4%4I+V1)>%01G3%.)/%1--+T101N3/%4@3,-5

F1)1-P-%,3]P1,3-3):4Z%%wS/+T3%F3/1.%&0.A3,%Hm%w!1)/+V4%_&m%wS:%03.4:%6'8/P6Q79?&8D76;//9+41)7[1>,+41)74:.1)3/%401/345

F97'2=>92;"@3,-%G1.T101:A

Sperm Viability (SV)


25/44


".

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &';KKKK p8H8

S//1+).0%4.-@034 &';KKKJ pJ;J

S//1:1+).0%,34P0:%,3@+,:1)> &';KKK6 pBB

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &';KJKK p66&%/F9D'2

L.43%@,+/P2: &';JKKK pJ8E

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &';JJKK pJ8E

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &';J6KK pE;

S//1+).0%4.-@034 &';J6KJ p6K

S//1:1+).0%,34P0:%,3@+,:1)> &';J6K6 p;E

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &';J8KK pJ8;



LH922/EHDC?268E/C29/M2&9//+//NDO2/'H&%%26U2E/C29/EHDC?268

F97=>'8/P6Q79?&8D76;//O1G3%01]P1/%W8-#YX%,3/%2300%W6-#Y%4.-@03%@.1,4%V1:I%+)3%;-#%/+)+,%4.-@03%*+,%2+-@.:1T101:A%:34:1)>5

R6&%M82E;SL=%>,+P@1)>%% % %%% ?+-@.:1T101:A%:34:1)>UI%W^Y%:A@1)>% % % %%% S):1T+/A%1/3):1*12.:1+)R)3b@32:3/%.):1T+/A%/3:32:1+)%%%% ^S'

Blood Bank (Immunohematology) Comprehensive (AB)

LH922/EHDC?268E/C29/M2&9//+//NDO2/'H&%%26U2E/C29/EHDC?268

F97=>'8/P6Q79?&8D76;//O1G3%01]P1/%W8-#YX%,3/%2300%W6-#Y%4.-@03%@.1,45

R6&%M82E;SL=%>,+P@1)>UI%W^Y%:A@1)>^S'

Blood Bank (Immunohematology) Limited (AR)


F97=>'8/P6Q79?&8D76;//K5C-#%43,P-%4.-@0345

R6&%M82;S):1)P203.,%.):1T+/A\%]P.01:.:1G3

ANA Immunoserology (XN)


F97=>'8/P6Q79?&8D76;//J-#%43,P-%4.-@0345R6&%M82E;

S):14:,3@:+0A41)%=%WS"=Y\%]P.01:.:1G3S):14:,3@:+0A41)%=%WS"=Y\%]P.):1:.:1G3

ASO Immunoserology (XS)


F97=>'8/P6Q79?&8D76;// J-#%43,P-%4.-@0345%%O+,%I1>I%43)41:1G1:A%?U&%-3:I+/4\%+,/3,%?.,/1.2%F.,Q3,4%+)%@.>3%JC5

R6&%M82E;?7,3.2:1G3%@,+:31)\%]P.01:.:1G3?7,3.2:1G3%@,+:31)\%]P.):1:.:1G3

CRP Immunoserology (XP)


F97=>'8/P6Q79?&8D76;//K5


26/44


"-

77@-((2.

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &';J&%/F9D'2

L.43%@,+/P2: &';JBKK pJBE

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &';JCKK pJH6

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &';JEKK pJEB


Analytes listed in black are regulated under CLIA 88. ** Not accepted by the CAP Laboratory Accreditation Program, see page 5 for more information


F97=>'8/P6Q79?&8D76;//#1]P1/%4.-@0345

S//7+)%@,+/P2:%1)20P/34%+)3%43:%+*%4.-@034%.)/%,3@+,:1)>%*+,%+)3%43:%+*%,34P0:4%.)/%2.)%+)0A%T3%+,/3,3/%1)%2+)dP)2+)%V1:I%:I3%% % % S):17$SD%W:+:.0%.):1T+/AYvv% %S):17$L2%W:+:.0%.):1T+/AY%% (>F%S):17$SD(>F%S):17$L2% % % S):17$?DS):17$L4%

Hepatitis (YB)


F97=>'8/P6Q79?&8D76;// #1]P1/%4.-@0345%%?+-@.:1T03%V1:I%,.@1/%.)/%:,./1:1+).0%:34:1)>%-3:I+/4%P43/%:+%:34:%*+,%S):17$(D%J%+,% S):17$(D%JX65%% ?+)*1,-.:+,A%,34P0:4%*,+-%S):17$(D%J%!34:3,)%L0+:%-3:I+/4%.,3%,3@+,:.T035

R6&%M82;S):17$(D

Anti-HIV (HV)


F97=>'8/ P6Q79?&8D76;// #1]P1/%4.-@034%1):3)/3/%*+,%V.1G3/%,.@1/%:34:%Q1:45%?+-@.:1T03%V1:I%,.@1/%Q1:4%P43/%:+%:34:%*+,%S):17$(DJ%+,%S):17$(D%JX65

R6&%M82;S):17$(D

Anti-HIV (Waived Methods) (HVW)


F97=>'8/P6Q79?&8D76;//J-#%43,P-%4.-@0345

R6&%M82E;%?+-@03-3):%W?8Y% (>S% % (>M?+-@03-3):%W?;Y% (>9\%:+:.0vv% (>F

Immunoproteins (IP)

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &';J;KK p8KK

S//1+).0%4.-@034 &';J;KJ pJ6K

S//7+)%@,+/P2:%W:+%$DY

&';J;K8 pJK6


F97=>'8/P6Q79?&8D76;//K5/+,*3,1\%(>MX(>F

Lyme Disease Serology (LY)


27/44


"A

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &';6KKK pJ;J

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &';66KK pJ;J

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &';68KK pJ;J

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &';6;KK pJB&%/F9D'2

L.43%@,+/P2: &';6JKK pEK

S//1+).0%4.-@034 &';6JKJ p8B

S//1:1+).0%,34P0:%,3@+,:1)> &';6JK6 p8K




F97=>'8/P6Q79?&8D76;//#1]P1/%4.-@034%1):3)/3/%*+,%:I3%]P.):1:.:1G3%.)/%]P.01:.:1G3%3G.0P.:1+)%+*%.):1T+/A%:+%',3@+)3-.%@.001/P-5%%():3)/3/%*+,%-3:I+/4%:I.:%3G.0P.:3%43,P-%4@321-3)4\%35>5\%U&U\%D^U#\%O'S\%F$S7'&\%'&&S\%'UR"'\%.)/%9#("S%Q1:45

R6&%M82E;"A@I1014%[+):,3@+)3-.0\%]P.01:.:1G3"A@I1014%',3@+)3-.0\%]P.01:.:1G3"A@I1014%[+):,3@+)3-.0\%]P.):1:.:1G3

Syphilis Serology (SS)


F97=>'8/P6Q79?&8D76;//K5C-#%43,P-%4.-@0345

R6&%M82;()*32:1+P4%-+)+)P203+414

Mono Immunoserology (ZM)


F97=>'8/P6Q79?&8D76;//K5C-#%43,P-%4.-@0345

R6&%M82;()*32:1+P4%-+)+)P203+414

Mono Immunoserology (Waived Methods) (MW)


F97=>'8/P6Q79?&8D76;//J-#%43,P-%4.-@0345R6&%M82E;

UI3P-.:+1/%*.2:+,\%]P.01:.:1G3UI3P-.:+1/%*.2:+,\%]P.):1:.:1G3

Rheumatoid Factor Immunoserology (ZR)


F97=>'8/P6Q79?&8D76;//J-#%43,P-%4.-@0345

R6&%M82E;UPT300.\%]P.01:.:1G3% % UPT300.\%]P.):1:.:1G3(>F%UPT300.\%]P.01:.:1G3

Rubella Immunoserology (XU)


28/44


29/44"K

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'&%/F9D'2

L.43%@,+/P2: &'&%/F9D'2

L.43%@,+/P2: &'&%/F9D'2

L.43%@,+/P2: &'&%/F9D'2

L.43%@,+/P2: &''8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &''8/P6Q79?&8D76;//F3:I.)+0%*1b3/%401/34%*+,%>,.-%4:.1)1)>5

F97'2=>92E;M,.-%,3.2:1+)% =,>.)14-%-+,@I+0+>A

Gram Stain (GS)


F97=>'8/P6Q79?&8D76;//S):1>3)%/3:32:1+)%1):3)/3/%*+,%)+)7V.1G3/%-3:I+/4%+)0A5

F97'2=>92E;/%W)P-T3,%@3,%4I1@-3):Y":,3@%S%.):1>3)%/3:32:1+)%W8Y% ":,3@%S%2P0:P,3%W6Y

Strep Group A Antigen / Culture (SC)


F97=>'8/P6Q79?&8D76;//S):1>3)%/3:32:1+)%1):3)/3/%*+,%)+)7V.1G3/%-3:I+/4%+)0A5F97'2=>92;

":,3@%S%.):1>3)%/3:32:1+)

Strep Group A Antigen (SA)


F97=>'8/P6Q79?&8D76;//():3)/3/%*+,%V.1G3/%-3:I+/4%+)0A5

F97'2=>92;":,3@%S%.):1>3)%/3:32:1+)

Strep Group A Antigen (Waived Methods) (WS)


F97=>'8/P6Q79?&8D76;//".-@034%*+,%":,3@%S%2P0:P,35

F97'2=>92;":,3@%S%2P0:P,3

Strep Group A Culture (ST)


F97=>'8/P6Q79?&8D76;//".-@034%*+,%":,3@%L%/3:32:1+)5

P=26!'&76/F97'2=>92E/Q79;":,3@%M,+P@%L

Strep Group B (SB)


30/44


#*

D4+1,'*((2.

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &''8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &''8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &''8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &''8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &''8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &''8/P6Q79?&8D76;//():3)/3/%*+,%-+032P0.,%-3:I+/45

F97'2=>92E;?I0.-A/1.%:,.2I+-.:14%/3:32:1+)[31443,1.%>+)+,,I+3.3%/3:32:1+)

CT/GC Detection (AC)


F97=>'8/P6Q79?&8D76;//():3)/3/%*+,%.):1>3)%/3:32:1+)%TA%9(S5

F97'2=>92E;?I0.-A/1.%:,.2I+-.:14%.):1>3)%/3:32:1+)

Chlamydia Antigen (CE)


F97=>'8/P6Q79?&8D76;//".-@034%*+,%M?%2P0:P,35

P=26!'&76/F97'2=>92E/Q79;

[31443,1.%>+)+,,I+3.3

Neisseria gonorrhoeae (GC)


F97=>'8/P6Q79?&8D76;//?+-@.:1T03%V1:I%L^%M3)3=I-%.)/%?3@I31/%M3)3_@3,:5

F97'2=>92E;?5%/1**12103%:+b1)%.)/X+,%.):1>3)%/3:32:1+)

Clostridium difficile (CD)

LS7/EHDC?268E/C29/M2&9//+//LH922/E&?C%2E/C29/EHDC?268F97=>'8/P6Q79?&8D76;//".-@034%*+,%"I1>.%'+b1)%J%.)/X+,%6%.)/%P)/1**3,3):1.:3/%

/3:32:1+)%-3:I+/45

F97'2=>92E;"I1>.%:+b1)%J%/3:32:1+)%%"I1>.%:+b1)%6%/3:32:1+)"I1>.%:+b1)%P)/1**3,3):1.:3/

Shiga Toxin (SHG)

LH922/EHDC?268E/C29/M2&9//+//NDO2/E&?C%2E/C29/EHDC?268/

F97=>'8/P6Q79?&8D76;// &,+23/P,34%014:3/%T30+V%.,3%*+,%.):1>3)%/3:32:1+)5%?+-@.:1T03%V1:I,5!?6K,0(a,#R,8?73@:R

F97'2=>92E/W.)

>3)%/3:32

+)%+*Y;M,+P@%L%":,3@$.3-+@I10P4%1)*0P3)N.3%:A@3%T[31443,1.%-3)1)>1:1/14%>,+P@%S\%?\%g\%!J81:1/14%>,+P@%L%+,%95%2+01%oJ":,3@:+2+22P4%@)3P-+)1.3

Bacterial Antigens (for meningitis) (BA)


31/44


#!

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'&%/F9D'2

L.43%@,+/P2: &'&%/F9D'2

L.43%@,+/P2: &''8/P6Q79?&8D76;// 9.2I% +,>.)14-% 14%@,343):3/% .:%03.4:%+)23%@3,% A3.,5%?+-@.:1T03%V1:I%&,3-13,%?.-@A%9(S5

P=26!'&76/F97'2=>92E/Q79;S3,+-+).4% % &0341+-+).4% D1T,1+?.-@A0+T.2:3,% ".0-+)300.% g3,41)1.% %95%2+01%=J'8/P6Q79?&8D76;//'I14%14%.)%3/P2.:1+).0%3b3,2143%1):3)/3/%:+%/+2P-3):%`SX2+-@3:3)2A%*+,%T1+0+>12.0%3-3,>3)2A%,34@+)43%41:P.:1+)45%%(:%@,+G1/34%4P,,+>.:3%+,>.)14-4%V1:I%2I.,.2:3,14:124%:I.:%-1-12%@+:3):1.00A%03:I.0%@.:I+>3)45%%"2+,34%.,3%)+:%:,.)4-1::3/%:+%.22,3/1:.:1+)%.>3)21345%%#.T4%P41)>%.)+:I3,%&'%@,+G1/3,%*+,%,3>P0.:+,A%-12,+T1+0+>A%2.)%+,/3,%:I14%43,G1235

":.:3%2++,/1).:+,4%2.)%.,,.)>3%:+%3),+00%.)/%*P)/%:I31,%,34@+)43%)3:V+,Q%

0.T+,.:+,1345%%'I3A%V100%,3231G3%2+@134%+*%.00%,3@+,:4%*+,%P43%1)%.44344-3):%.)/%/+2P-3):.:1+)%+*%[email protected]:A\%,3./1)344\%.)/%:,.1)1)>%)33/45%%&03.43%2.00%EKK7;B67&%/F9D'2

L.43%@,+/P2:4

()/1G1/P.0%0.T4 &'B66KK p6JK

":.:3%2++,/1).:+,4 &'K6K6K p6JK


32/44


#"

=.+(

4+1,'

(2.



B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'B6KJK p6CK

B9=29/BC8D76EF97=>'8/LMC2 F97=>'8/

@7=2R66>&%/

F9D'2

L.43%@,+/P2: &'B6K6K p66K

LS7/EHDC?268E/C29/M2&9//+//NDO2/E&?C%2E/C29/EHDC?268

F97=>'8/P6Q79?&8D76;//():3)/3/%*+,%,3@+,:1)>%:I3%e@,343)23%+,%.T43)23f%+*%.21/7*.4:%T.210015

S//7+)%@,+/P2:%1)20P/34%+)3%43:%+*%4.-@034%.)/%,3@+,:1)>%*+,%+)3%43:%+*%,34P0:4%.)/%2.)%+)0A%T3%+,/3,3/%1)%2+)dP)2+)%V1:I%FA2+T.2:3,1+0+>A%?P0:P,3%WFLY%T.43%@,+/P2:5

F97'2=>92;S21/7*.4:%4:.1)

Acid-Fast Stain (MA)

LS7/EHDC?268E/C29/M2&9//+//NDO2/E&?C%2E/C29/EHDC?268

F97=>'8/P6Q79?&8D76;//".-@034%*+,%F5:PT3,2P0+414%2P0:P,35

F97'2=>92;F5%:PT3,2P0+414%42,33)%TA%2P0:P,3

Mycobacteriology Culture (MB)


F97=>'8/P6Q79?&8D76;// ():3)/3/%*+,%F5:PT3,2P0+414% /3:32:1+)% TA%-+032P0.,%-3:I+/45

F97'2=>92;F5%:PT3,2P0+414%/3:32:1+)

M. tuberculosis by Molecular Methods (TB)

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'B6KKK pJ;K

S//7+)%@,+/P2:%W:+%FLY &'B6KK8 pCK


33/44


##

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'BKKKK p6HJ

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'BKJKK p6'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'BK6KK p6JK

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'BK8KK p68;



LH922/EHDC?268E/C29/M2&9//+//JD0/E&?C%2E/C29/EHDC?268

F97=>'8/P6Q79?&8D76;// ():3)/3/%*+,%0.T+,.:+,134%:I.:%,3@+,:%+,>.)14-4%TA%>3)P4%.)/X+,%4@321345%%".-@034%1)20P/3%*P)>.0%2P0:P,34%W1)20P/1)>%A3.4:%.)/%/3,-.:+@IA:34Y%.)/%.:%03.4:%:V+%01]P1/%2,A@:+2+22.0%.):1>3)%4.-@034%@3,%A3.,5

F97'2=>92E;F+0/\%A3.4:%.)/%eA3.4:701Q3f%+,>.)14-%1/3):1*12.:1+)?,A@:+2+22.0%.):1>3)%/3:32:1+)

Mycology Comprehensive (MY)


F97=>'8/P6Q79?&8D76;//[+:%1):3)/3/%*+,%V3:%-+P):%@,3@.,.:1+)45

F97'2=>92E;g3.4:%.)/%eA3.4:701Q3f%+,>.)14-%1/3):1*12.:1+)

Mycology Yeast (YE)


F97=>'8/P6Q79?&8D76;//"1-P0.:3/%?"O%4.-@034%*+,%?,A@:+2+22.0%.):1>3)%/3:32:1+)5

F97'2=>92E;?,A@:+2+22.0%.):1>3)%/3:32:1+)

Mycology Cryptococcal Antigen (MYC)


F97=>'8/P6Q79?&8D76;//'V+/,3@+,:1)>%+@:1+)4

`P.01:.:1G3%7%^341>)3/%*+,%0.T+,.:+,134%+,%/3,-.:+0+>A%+**1234%,3@+,:1)>%:I3%t@,343)23%+,%.T43)23t%+*%/3,-.:+@IA:345%%W?+-@.:1T03%V1:I%^3,-.:+@IA:3%'34:%F3/1P-%x^'Fy%+,%)+)[email protected]/%.)/%)+)7/1**3,3):1.0%-A2+0+>A%-3/1.5Y

(/3):1*12.:1+)%7%^341>)3/%*+,%0.T+,.:+,134%+,%/3,-.:+0+>A%+**1234%1/3):1*A1)>%/3,-.:+@IA:34%:+%.%>3)P4%+,%4@32134%03G305

F97'2=>92E;^3,-.:+@IA:3%42,33)%TA%2P0:P,3%W`P.01:.:1G3Y^3,-.:+@IA:3%1/3):1*12.:1+)%:+%>3)P4%+,%4@32134%03G30%W(/3):1*12.:1+)Y

Mycology Dermatophyte (DM)


34/44


#,

%4'40*1(5(2.



B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'BJKKK p6'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'BJJKK p666

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'BJ6KK p68;

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2 R66>&%/F9D'2

L.43%@,+/P2: &'BJ8KK p68C

LH922/EHDC?268E/C29/M2&9//+//JD0/E&?C%2E/C29/EHDC?268

F97=>'8/P6Q79?&8D76;//():3)/3/%*+,%#3G30%6%0.T+,.:+,134%W.4%/3*1)3/%TA%?#(S%aEEY%@3,*+,-1)>%*P00%=z&%1/3):1*12.:1+)%+*%4:++0%4@321-3)45%%".-@03%:A@34%1)20P/3%*+,-.01)7@,343,G3/%4:++0\%N1)27&DS%4:++0%4-3.,4\%.)/%T0++/%@.,.41:3%4-3.,4X@I+:+-12,+>,.@I45%%".-@034%.,3%)+:%2+-@.:1T03%V1:I,$9!6A7%/3G12345

F97'2=>92E;L0++/%@.,.41:3%1/3):1*12.:1+)% % &3,-.)3):%4:.1)

M1.,/1.X?,A@:+%.):1>3)%/3:32:1+)% ":++0%V3:%-+P):F+/1*13/%.21/7*.4:%4:.1)

Parasitology Comprehensive (PA)


F97=>'8/P6Q79?&8D76;// ():3)/3/%*+,%0.T+,.:+,134%:I.:%/+% )+:%@3,*+,-%*P00%=z&%1/3):1*12.:1+)%+*%4:++0%4@321-3)45%%".-@03%:A@34%1)20P/3%*+,-.01)7@,343,G3/%4:++04\%.)/%T0++/%@.,.41:3%4-3.,4X@I+:+-12,+>,.@I45%%".-@034%.,3%)+:%2+-@.:1T03%V1:I,$9!6A7%/3G12345

F97'2=>92E;//W)P-T3,%@3,%4I1@-3):YL0++/%@.,.41:3%1/3):1*12.:1+)%W6YM1.,/1.X?,A@:+%.):1>3)%/3:32:1+)%W8Y

Parasitology Limited (PAL)


F97=>'8/P6Q79?&8D76;//():3)/3/%*+,%0.T+,.:+,134%@3,*+,-1)>%M1.,/1.%.)/X+,%?,A@:+4@+,1/1P-% 42,33)1)>% +)%4:++0%4.-@0345% % ".-@034% .,3%)+:%2+-@.:1T03%V1:I,$9!6A7%/3G12345

F97'2=>92E;M1.,/1.%.)/X+,%?,A@:+4@+,1/1P-%.):1>3)%/3:32:1+)

Giardia/Cryptosporidium Antigen Detection (GI)


F97=>'8/ P6Q79? &8D76; / / ".-@034% 1)20P/3% >13-4.74:.1)3/% 4-3.,4% .)/%

@I+:+-12,+>,.@I4%+*%:I12Q%.)/%:I1)%T0++/%4-3.,45


35/44


#.

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'B8KKK p6EE

S//1+).0%4.-@034 &'B8KKJ pJ &'B8KK6 p'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'B86KK pJCE

S//1+).0%4.-@034 &'B86KJ pBK

S//1:1+).0%,34P0:%,3@+,:1)> &'B86K6 p;E



Viral Antigens with Rotavirus (VA)

LS7/EHDC?268E/C29/M2&9

F97=>'8/P6Q79?&8D76;//S%-1)1-P-%+*%J34%@3,%A3.,m%/P.0%1-@,3441+)4%+)%'3*0+)72+.:3/%401/345%%&,+/P2:4%.,3%-3:I+/%4@321*125

^301G3,A%V100%T3%G1.%+G3,)1>I:%2+P,13,5%%?P4:+-3,4%-P4:%-.Q3%.,,.)>3-3):4%:+%.223@:%/301G3,A%.)/%I.G3%@.2Q.>3%,+P:3/%1--3/1.:30A%:+%:I3%0.T%*+,%.@@,+@,1.:3%I.)/01)>X4:+,.>35%

R6&%M82;

U.T134%S):1>3)

Rabies


F97=>'8/P6Q79?&8D76;//#1]P1/%4.-@034%1):3)/3/%*+,%,.@1/%.):1>3)%:34:%Q1:45

R6&%M82E;()*0P3)N.%S% % ()*0P3)N.%SXL%W)+:%/1**3,3):1.:3/Y()*0P3)N.%L% % U"D

Viral Antigens - Influenza and/or RSV (VFR)


F97=>'8/P6Q79?&8D76;//#1]P1/%4.-@034%1):3)/3/%*+,%,.@1/%.):1>3)%:34:%Q1:45%%".-@034%.,3%)+:%2+-@.:1T03%V1:I%:I3%D/M%#,+$D%Q1:5

R6&%M82;()*0P3)N.%S% % % % U"D%()*0P3)N.%L% % % % U+:.G1,P4()*0P3)N.%SXL%W)+:%/1**3,3):1.:3/Y% % %


F97=>'8/P6Q79?&8D76;//#1]P1/%4.-@034%1):3)/3/%*+,%V.1G3/%,.@1/%.):1>3)%:34:1)>%Q1:45

R6&%M82E;()*0P3)N.%S% % ()*0P3)N.%SXL%W)+:%/1**3,3):1.:3/Y()*0P3)N.%L% % U"D

Viral Antigens - Influenza and/or RSV (Waived Methods) (VCW)

B9=29/BC8D76E

F97=>'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2:4

'34:1)>%TA%^OS%WUSY &'B6JKK p8HE

'34:1)>%TA%/U('%WUSDY &'B6JJK p8HE

S//1:1+).0%,34P0:%,3@+,:1)> &'B6JK6 p'8/LMC2 F97=>'8/@7=2

R66>&%/F9D'2

L.43%@,+/P2: &'B8JKK p86;


36/44


#-

JH

*;;*-

&+

,

@

VW:G/ /

%U3>%"I1@%M,+P@%W"I1@-3):%8Y

B@LB[GT/

J% L0++/%L.)Q%"I1@%M,+P@%W"I1@-3):%8Y

E% L.2%`S%"I1@%M,+P@%W"I1@-3):%6YL.2%U3>%"I1@%M,+P@%W"I1@-3):%8Y

J%"I1@%M,+P@%W"I1@-3):%8Y

66% ?I3-%`S%"I1@%M,+P@%W"I1@-3):%6Y68% D1,.0%U3>%"I1@%M,+P@%W"I1@-3):%8Y

D1,.0%!.1G3/%"I1@%M,+P@%W"I1@-3):%6Y

6H% L0++/%#3./%U3>%"I1@%M,+P@%W"I1@-3):%8YU.T134%"I1@%M,+P@%W"I1@-3):%6Y

:BIG%"I1@%M,+P@%W"I1@-3):%JY

68% R,1)3%F12,+%"I1@%M,+P@%W"I1@-3):%JY

8K% ?+.>%U3>%"I1@%M,+P@%W"I1@-3):%JY

NG[TWRTY/

B% $(D%!.1G3/%"I1@%M,+P@%W"I1@-3):%JY% "$$%"I1@%M,+P@%W"I1@-3):%JY

C% ?I3-%'+b1%"I1@%M,+P@%W"I1@-3):%JY

J8% ?+.>%`S%"I1@%M,+P@%W"I1@-3):%JY

6J% $3-3%U3>%"I1@%M,+P@%W"I1@-3):%JY

6C% 'L%"I1@%M,+P@%W"I1@-3):%JY% L0++/%#3./%`S%"I1@%M,+P@%W"I1@-3):%JY

%"I1@%M,+P@%W"I1@-3):%JY% D1,.0%U3>%"I1@%M,+P@%W"I1@-3):%6Y

6C% ?I3-%`S%"I1@%M,+P@%W"I1@-3):%JY%

RFTPX/ /

6% ?I3-%!.1G3/%"I1@%M,+P@%W"I1@-3):%JY% $3-3%`S%"I1@%M,+P@%W"I1@-3):%JY%

JB% L1+:3,,+,14-%&,3@%"I1@%M,+P@%W"I1@-3):%JY%

% L+/A%O0P1/%?I3-%"I1@%M,+P@%W"I1@-3):%JY6;% ?.,/1.2%`S%"I1@%M,+P@%W"I1@-3):%JY% ?.,/1.2%U3>%"I1@%M,+P@%W"I1@-3):%6Y

8K% U.T134%"I1@%M,+P@%W"I1@-3):%JY

%"I1@%M,+P@%W"I1@-3):%6Y"@321.0%F12,+%"I1@%M,+P@%W"I1@-3):%6Y

J;% ("%U3>%"I1@%M,+P@%W"I1@-3):%6Y

6J% ?+.>%U3>%"I1@%M,+P@%W"I1@-3):%6Y% "$$%"I1@%M,+P@%W"I1@-3):%6Y

6H% ?I3-%'+b1%"I1@%M,+P@%W"I1@-3):%6


37/44


#ANOTE: Samples for products within ship groups are normally shipped together in one box.

Shipments are sent for second-day delivery. Arrangements must be made to accept delivery.

"I1@%M,+P@ "I1@-3): J "I1@-3): 6 "I1@-3): 8

&,+/P2:%[.-3 "I1@%^.:3 ^P3%^.:3 "I1@%^.:3 ^P3%^.:3 "I1@%^.:3 ^P3%^.:3

L.2%`S%"I1@%M,+P@

"I1>.%'+b1) 8X3)4%*+,%-3)1)>14 8XA%?+-@,3I3)41G3 8XA%#1-1:3/ 8X3) 8XA 8X


38/44


NOTE: Samples for products within ship groups are normally shipped together in one bo

Shipments are sent for second-day delivery. Arrangements must be made to accept deliver#)

JH

*;;*-

&+

,

@

"I1@%M,+P@ "I1@-3): J "I1@-3): 6 "I1@-3): 8

&,+/P2:%[.-3 "I1@%^.:3 ^P3%^.:3 "I1@%^.:3 ^P3%^.:3 "I1@%^.:3 ^P3%^.:3

L+/A%O0P1/%?I3-14:,A%"I1@%M,+P@

L+/A%O0P1/%?I3-14:,A ;XJBXJ6% 3 JXJKXJ6% JX6CXJ6 ;X6;XJ6 P0.+) 6XJ8XJ6 8X6XJ6 EXJ8XJ6 EX8JXJ6

?+.>%U3>%"I1@%M,+P@

?+.>P0.+)%L.412 JX8KXJ6 6XJCXJ6 P?I3Q%_"%&0P4 JX8KXJ6 6XJCXJ6


39/44


NOTE: Samples for products within ship groups are normally shipped together in one box.

Shipments are sent for second-day delivery. Arrangements must be made to accept delivery. #K

"I1@%M,+P@ "I1@-3): J "I1@-3): 6 "I1@-3): 8

&,+/P2:%[.-3 "I1@%^.:3 ^P3%^.:3 "I1@%^.:3 ^P3%^.:3 "I1@%^.:3 ^P3%^.:3

$3-3%`S%"I1@%M,+P@

L+/A%O0P1/%?300%?+P):%.P:+-.:3/ ;X6XJ6 ;X6KXJ6 HXJCXJ6 JKXA%L.412 6X6JXJ6 8XHXJ6 A JXJCXJ6% 6X6XJ6 HX


40/44,*


JH

*;;*-

&+

,

@

NOTE: Samples for products within ship groups are normally shipped together in one bo

Shipments are sent for second-day delivery. Arrangements must be made to accept deliver

"I1@%M,+P@ "I1@-3): J "I1@-3): 6 "I1@-3): 8

&,+/P2:%[.-3 "I1@%^.:3 ^P3%^.:3 "I1@%^.:3 ^P3%^.:3 "I1@%^.:3 ^P3%^.:3

U.T134%"I1@%M,+P@

U.T134%TA%^OS ;X8KXJ6% A%?P0:P,3 6X6CXJ6 ;X68XJ6 HXJCXJ6 JJXJ6XJ6

R,1)3%F12,+%"I1@%M,+P@

&,+G1/3,%&3,*+,-3/%F12,+42+@A JX68XJ6 6XJKXJ6 EXBXJ6 EX6;XJ6

R,1).0A414XR,1)3%I?M JX68XJ6 6XJKXJ6 EXBXJ6 EX6;XJ6

R,1)3%I?M%3)4%7%()*0P3)N.%.)/%U"D JXHXJ6 JX6CXJ6 8X6BXJ6 ;XJ8XJ6 JKX68XJ6 JJXHXJ6

D1,.0%!.1G3/%"I1@%M,+P@

D1,.0%S):1>3)4%7%()*0P3)N.%.)/%U"D%V.1G3/%-3:I+/4 JXHXJ6 JX6CXJ6 JKX68XJ6 JJXHXJ6


41/44


R%SX?%,.+ %%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5J;SL=%>,+P@1)>%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%56%-3%WS?'Y %5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5JHS2G.:3/%@.,.0%:I,[email protected])%-3%WS&''Y%5%%5%%5%%5%%5%%5%%5%%5%%5%%5JE

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o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email protected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email protected]%7%S)7$SD%W:+:.0%.)T+/AY%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%56B

[email protected]%7%S)7$L2%W:+:.0%.)T+/AY%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%[email protected]%7%S)7$L4%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%[email protected]%7%S)7$?D %5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%[email protected]%7%$L4S>%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%[email protected]%7%(>F%S)7$SD5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%[email protected]%7%(>F%S)7$L2%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%56B$(D%WS)7$(DY %%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%56B$+-+2A4:31)3%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5J8I47?U&%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5JC%P%(2:+:34:%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%568(>S%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%56B(>9\%:+:.0 %%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%56B(>M%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%56B

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

#.2:+*3,,1)%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%566#3PQ+2A:3%34:3,.43%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%568#3PQ+2A:34\%*32.0%4-3.,%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%568#[email protected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

[31443,1.%>+)+,,I+3.3 %%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%6E\8K[31443,1.%-3)1)>1/14%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%58K[1:,1:3%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%568[F&66%@,+:31)%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5J8['%@,+L[&%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5JC%B%=22P0:%T0++/\%*32.0%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%566=22P0:%T0++/\%>.4:,12%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%566=@1.:34 %5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5J;=,>.)14-%-+,@I+0+>A%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%6E\6H=4-+0.01:A %%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5JJ=4-+0.01:A\%P,1)3%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5J;=bA2+/+)3 %5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5J;=bAI3-+>0+T1) %%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5JK

%F%&SFM7J%@,+:31)\%.-)1+2%"P1/%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%566&.,.41:+0+>A5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%58;@?=6 %%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5JK&3,-.)3):%4:.1)%W*+,%@.,.41:+0+>AY%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%58;

,"

-

,K


43/44,#

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bA@I3)3%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5J;&,+4:.:3%4@321!2%.)>3)%W&"SY %5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5J8&,+:31)\%T+/A%"P1/%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5J;&,+:31)\%?"O%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5J;&,+:31)\%:+:.0%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%JJ\J6

&,+:31)\%P,1)3%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5J;&,+:31)\%P,1)3%/1@42Q%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%568&,+-3%W&'Y%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5JE&,+G1/3,%&3,*+,-3/%F12,+42+@A%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%568&'$%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5J8%^%`P1)1/1)3%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5JJ%T%U.T134%S)>3)%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%58.%:+b1)%P)/13,3).:3/%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%58K"I1>300. %5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%58J

"12Q03%2300%42,33)%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%56J"+/1P-%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%JK\JJ\J6"+/1P-\%?"O %%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5J;"+/1P-\%P,1)3 %%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5J;"@321!2%>,.G1:A%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%568"@3,-%2+P):%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%56;"@3,-%-+,@I+0+>A %%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%56;"@3,-%-+01:A %5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%56;"@3,-%G1.T101:A%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%56;

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

'8%R@:.Q3%X%'7R@:.Q3%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5JJ'34:+4:3,+)3\%:+:.0%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5J8'I3+@IA001)3 %5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5JJ'I3,.@3P2%^,P>4%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5JJ'IA,+1/74-P0.)>%I+,-+)3%W'"$Y%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5%%5JJ'IA,+b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

Univ of WI PT

Documents

Transcript of Univ of WI PT